retatrutide news recency 3 🚨Breaking: Retatrutide's first Phase T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending What caught my attention wasn't

The Pill Problem: Oral GLP-1s can affect the absorption of other medications, including oral contraceptives, requiring careful consideration and potential adjustments in dosing schedules

Some people achieve excellent results with semaglutide and see no reason to spend extra for tirzepatide

At The Adapt Lab, we combine medical expertise with personalized treatment to deliver safe and effective results

Lilly also said it saw no heart or liver issues in the data

8-16 weeks: Weight loss typically becomes more consistent as doses are titrated upward and appetite suppression becomes more pronounced

Without coverage$620/mo cap, $8,060/year cap